Comparison of the Pharmacokinetics, Safety and Tolerability of Two Concentrations of a New Liquid Recombinant Human Growth Hormone Formulation versus the Freeze-dried Formulation

Bernd Liedert; Ulf Forssmann; Peter Wolna; Michaela Golob; Andreas Kovar


BMC Clin Pharmacol. 2010;10(14):1-7. 

In This Article


The two strengths of the liquid multi-dose formulation of r-hGH are bioequivalent to the FD multi-dose reference formulation and are well tolerated. This conclusion is robust to adjustments for the active content and the actual dose administered.